These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34779221)

  • 1. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
    Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
    Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous or Transvenous Defibrillator Therapy.
    Knops RE; Olde Nordkamp LRA; Delnoy PHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; van der Stuijt W; de Weger A; de Wilde KC; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Tijssen JGP; Wilde AAM;
    N Engl J Med; 2020 Aug; 383(6):526-536. PubMed ID: 32757521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
    Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
    Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R;
    J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
    Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
    Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Subcutaneous Implantable Cardioverter Defibrillator.
    Mangels D; Frishman WH
    Cardiol Rev; 2016; 24(5):248-55. PubMed ID: 26807549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
    Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
    JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
    Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
    Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy.
    Jankelson L; Garber L; Sherrid M; Massera D; Jones P; Barbhaiya C; Holmes D; Knotts R; Bernstein S; Spinelli M; Park D; Aizer A; Chinitz L
    Heart Rhythm; 2022 May; 19(5):759-767. PubMed ID: 35038570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
    Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
    J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.
    Gold MR; Theuns DA; Knight BP; Sturdivant JL; Sanghera R; Ellenbogen KA; Wood MA; Burke MC
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):359-66. PubMed ID: 22035049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.